lobbying_activities: 2030017

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2030017	eac501fa-e1a9-48b2-8218-271b1e4a5be3	Q3	ACG ADVOCACY	2057	ROIVANT SCIENCES, INC.	2017	third_quarter	PHA	Drug Pricing. Innovation Issues.	HOUSE OF REPRESENTATIVES,SENATE	80000		0	0	2017-10-18T14:10:42.247000-04:00